Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,057 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study

NCT01032889

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Investigational Site Birmingham, Alabama, United States
  • Investigational Site Beverly Hills, California, United States
  • Investigational Site Beverly Hills, California, United States
  • Investigational Site San Francisco, California, United States
View Trial Details
Completed

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

NCT01542034

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Investigational Site Birmingham, Alabama, United States
  • Investigational Site Beverly Hills, California, United States
  • Investigational Site Beverly Hills, California, United States
  • Investigational Site Irvine, California, United States
View all 36 locations
View Trial Details
Completed

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

NCT01546142

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Investigational Site Little Rock, Arkansas, United States
  • Investigational Site Beverly Hills, California, United States
  • Investigational Site Los Angeles, California, United States
  • Investigational Site Sacramento, California, United States
View all 35 locations
View Trial Details
Completed

Evaluation of Safety and Efficacy of Deoxycholic Acid Injection (ATX-101) in the Reduction of Submental Fat

NCT01294644

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Investigational Site Geel, Belgium
  • Investigational Site Genk, Belgium
  • Investigational Site Besançon, France
  • Investigational Site Nice, France
View all 29 locations
View Trial Details
Completed

A Study of LY2875358 in Japanese Participants With Advanced Cancer

NCT01602289

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
View Trial Details

Related conditions